Research in the fields of biotechnology, bioinformatics, and life sciences is making breathtaking progress. Computer-based methods, as well as the simulation and analysis of vast amounts of data, play a central role in this—and so does a powerful IT infrastructure that makes it all possible. For the IMBA (Institute of Molecular Biotechnology) & IMP (Research Institute of Molecular Pathology), the increasing digitalization of the R&D sector is also becoming a crucial factor in securing a leading position in international competition.
Read more from page 22 about the digital transformation strategy defined by IMBA & IMP: >>> CIO GUIDE Digital Talks Print Special <<<